Catalyst Wire Dossier Catalyst Wire Dossier

Turoctocog alfa (N8)

turoctocog alfa · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Turoctocog alfa (N8), covering 2017-07-27 to 2017-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 [Phase 3]

See pricing